Presbyopia

ATHENS, Greece — In this Healio Video Perspective from the ESCRS winter meeting, Ramza Diamanti, MD, discusses the importance of patient communication when using presbyopia-correcting lenses.

The FDA granted fast track designation to phentolamine ophthalmic solution 0.75% to treat significant chronic night driving impairment in patients who have undergone keratorefractive surgery.

Orasis Pharmaceuticals is announcing the U.S. launch of Qlosi at SECO 2025 in Atlanta.

ORLANDO — Surgeons need to understand the personality traits of patients with presbyopia to set proper expectations for multifocal IOL surgery.

When Bette Davis said, “Old age ain’t for sissies,” she might have been referring to the challenge of correcting presbyopia.

Few conditions impact as many people worldwide as presbyopia. Recent estimates have placed the prevalence of presbyopia in the 2 billion range.

Presbyopia is the second most common refractive error in the United States, with about 128 million of 335 million Americans, or 38% of the population, being presbyopic. Myopia today is slightly higher at 42% of the population.

When patients come to my office for comprehensive eye exams, common questions, especially for those who are in the early stages of presbyopia, include, “Why am I losing vision?” and, more importantly, “How can this be treated?”

KOLOA, Hawaii — Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a presenter at Hawaiian Eye 2025.

Occasionally, treatments come along that are of greater interest to patients than to doctors.